Biodesix (BDSX) Amortization of Deferred Charges (2019 - 2021)

Biodesix (BDSX) has 5 years of Amortization of Deferred Charges data on file, last reported at $328000.0 in Q4 2023.

• Quarterly Amortization of Deferred Charges fell 56.15% year-over-year to $328000.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $2.2 million (down 3.03% YoY) and the FY2023 annual result came in at $2.2 million, down 3.03% from the prior year.
• Amortization of Deferred Charges fell to $328000.0 in Q4 2023, from $457000.0 in the prior quarter.
• In the past five years, Amortization of Deferred Charges ranged from a high of $771000.0 in Q3 2022 to a low of $35000.0 in Q4 2019.
• A 5-year average of $381083.3 and a median of $388000.0 in 2022 frame the typical range for Amortization of Deferred Charges.
• Annual changes were most pronounced in 2022 — Amortization of Deferred Charges surged 582.93% — and 2023, when it plunged 56.15%.
• Tracing BDSX's Amortization of Deferred Charges over 5 years: stood at $35000.0 in 2019, then changed by 0.0% to $35000.0 in 2020, then rose by 17.14% to $41000.0 in 2021, then soared by 1724.39% to $748000.0 in 2022, then sank by 56.15% to $328000.0 in 2023.
• The last three Amortization of Deferred Charges figures came in at $328000.0 (Q4 2023), $457000.0 (Q3 2023), and $634000.0 (Q2 2023), per Business Quant data.